Target intelligence / Profile preview

Echis ocellatus disintegrins

Molecular classification
Venom protein, Disintegrin family, Integrin antagonist, Non-enzymatic protein
01

Overview

Echis ocellatus disintegrins are a family of small, cysteine-rich, non-enzymatic proteins found in the venom of the West African carpet viper, Echis ocellatus [1, 2]. These molecules are primarily known for their potent ability to inhibit platelet aggregation and cell-matrix interactions by binding to integrin receptors, such as the fibrinogen receptor (alpha-IIb-beta-3) and the vitronectin receptor (alpha-v-beta-3) [3, 4]. Most members of this family contain a conserved Arg-Gly-Asp (RGD) motif that mimics the binding sites of natural extracellular matrix ligands, allowing them to act as competitive antagonists [1, 5]. In the context of snakebite pathology, these disintegrins contribute significantly to the venom-induced consumption coagulopathy and systemic hemorrhage by preventing the formation of stable platelet plugs [2, 6]. Beyond their role as toxins, they have been extensively studied as pharmacological tools and lead compounds for developing anti-thrombotic and anti-angiogenic therapies [4, 7]. Their high affinity and specificity for integrins make them valuable for investigating cell signaling and potential treatments for cancer metastasis [3, 8].

Other names
OcellatusinCarpet viper disintegrinsRGD-containing venom proteinsEchis ocellatus venom disintegrins
02

Mechanism of action

Antivenom antibodies bind to the disintegrin molecules, sterically hindering their ability to interact with cellular integrins and facilitating their clearance from circulation [2, 6, 8].

03

Biological functions

Inhibition of platelet aggregationCell-matrix adhesion inhibitionIntegrin antagonismAngiogenesis inhibition
04

Disease associations

Snakebite envenomationThrombosisCancer metastasisAngiogenesis-related disorders
05

Safety considerations

HemorrhageSystemic bleedingThrombocytopeniaImmunogenicity of antivenomAnaphylaxis
06

Interacting drugs

EchiTAbG

2 more in the full profile.

07

Biomarkers

Platelet aggregation inhibitionBleeding timeFibrinogen levelsIntegrin binding assays

Beyond the preview

Go deeper on Echis ocellatus disintegrins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Echis ocellatus disintegrins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call